pipette
ESEspañol

A tuneable structural switch controls RNF213 activity and is bypassed in Moyamoya disease

L. E. Bell, V. Faas, D. B. Grabarczyk, M. H. Wallnöfer, E. Kohoutkova, L. Deszcz, T. L. Williams, A. Meinhart, H. Scott, F. Riant, C. Aloui, M. Kossorotoff, L. Lacan, F. Godart, E. Tournier-Lasserve, A. J. Fletcher, T. Clausen

Preprint

In the authors' words

RNF213 is a giant AAA+ ubiquitin ligase that serves as a central hub of innate immunity, responding to diverse stress signals with broad reactivity. This versatility demands tight regulation, and its failure causes disease, such as Moyamoya angiopathy and cancer progression. How the mega-enzyme is restrained and how mutations override this control is unknown. Here, we show that RNF213 activity is regulated by a dimeric switch - a constitutive dimer that alternates between auto-inhibited and activation-competent states. In the closed dimer, intermolecular contacts bury the E3 machinery, whereas ATP binding remodels the AAA+ core to open the dimer and prime ubiquitination. Dimer conversion is tuned by ubiquitination factors, redox conditions and post-translational modifications, allowing multiple stress signals to act through the same activation mechanism. Moyamoya mutations subvert the same open-closed transition, destabilizing the auto-inhibited dimer in a graded manner that tracks with clinical severity. Structural, biochemical and cellular data reveal how disease mutations allosterically disrupt the dimer interface and bypass ATP-dependent control to drive NF-{kappa}B activation and caspase-dependent apoptosis. Together, our findings reveal a tuneable dimeric switch that converts diverse stressors into graded inflammatory signalling and provide a mechanistic link between genetic predisposition, environmental triggers and Moyamoya disease.

Main resultThe abstract does not state a limitation.

In plain words AI summary

RNF213 is a large immune system enzyme that responds to many stress signals. The enzyme is controlled by a dimeric switch that flips between inactive and active states. ATP binding opens the switch to start ubiquitination, a protein tagging process. Moyamoya disease mutations destabilize the inactive state and bypass ATP control. The mutations cause graded effects that match clinical severity and drive inflammation and cell death.

Written by Kimi K2.5 using only the abstract above. Jev checked that every sentence is supported by the abstract sentences it cites, and removed any that were not. Point at a sentence to highlight its source.

Appeared: Monday, October 12. medRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.10.07.26364583